Cite

HARVARD Citation

    Reinert, R. et al. (2010). Advances in pneumococcal vaccines: the 13-valent pneumococcal conjugate vaccine received market authorization in Europe. Expert review of vaccines. pp. 229-236. [Online]. 
  
Back to record